NeoGenomics (NEO) Tops Q4 EPS by 1c, Slgiht Beat on Revenues; Offers FY18 EPS/Revenue Outlook Below Consensus
Tweet
Share
E-mailGet Alerts NEO Hot Sheet
Join SI Premium – FREE
NeoGenomics (NASDAQ: NEO) reported Q4 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $67.8 million versus the consensus estimate of $66.25 million.
GUIDANCE:
NeoGenomics sees FY2018 EPS of $0.15-$0.20, versus the consensus of $0.21. NeoGenomics sees FY2018 revenue of $260-270 million, versus the consensus of $281.06 million.
For earnings history and earnings-related data on NeoGenomics (NEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Creatd files Form S-1 and reports Q1 2026 financial results
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
